A clinical case of migrainous stroke
https://doi.org/10.20538/1682-0363-2023-2-176-181
Abstract
Migrainous stroke is a rare combination of frequently occurring diseases; only a few cases have been described in the domestic literature. The complexity of differential diagnosis is due to the fact that at the stage of initial manifestations, these two conditions can mimic each other. Treatment strategy and further prevention for each of these diseases is different, so timely and convincing early diagnosis is crucial. The presented clinical case describes a case of ischemic stroke in a young woman who had been suffering from migraine for a long time, which did not fully meet the criteria for migrainous infarction. The patient was treated at the regional vascular center of the Tomsk Regional Clinical Hospital, there was a positive trend in the neurological status. The catamnesis of the disease was tracked. It was suggested that endothelial dysfunction is the main pathogenetic factor in the formation of an ischemic focus against the background of a protracted migraine attack.
About the Authors
D. M. Plotnikov
Siberian State Medical University (SSMU)
Russian Federation
Russian Federation
2, Moscow Trakt, Tomsk, 634050
V. M. Alifirova
Siberian State Medical University (SSMU)
Russian Federation
Russian Federation
2, Moscow Trakt, Tomsk, 634050
E. S. Mosienko
Tomsk Regional Clinical Hospital
Russian Federation
Russian Federation
96, I. Chenykh Str., Tomsk, 634063
References
1. Табеева Г.Р. Цереброваскулярные расстройства, ассоциированные с мигренью. Медицинский совет. 2017;(10):32–35.
2. The international classification of headache; 3rd ed. Cephalalgia. 2018;38(1):1–211. DOI: 10.1177/0333102417738202.
3. Gryglas A., Smigiel R. Migraine and Stroke: What’s the Link? What to do? Curr. Neurol. Neurosci. Rep. 2017;17(3):22. DOI: 10.1007/s11910-017-0729-y.
4. Etminan M., Takkouche B., Isorna F.C., Samii A. Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies. BMJ. 2005;330(7482):63–65. DOI: 10.1136/bmj.38302.504063.8F.
5. Schurks M., Rist P.M., Bigal M.E., Buring J.E., Lipton R.B., Kurth T. Migraine and cardiovascular disease: systematic review and meta-analysis. BMJ. 2009;339:b3914. DOI: 10.1136/bmj.b3914.
6. Spector J.T., Kahn S.R., Jones M.R., Jayakumar M., Dalal D., Nazarian S. Migraine headache and ischemic stroke risk: an updated meta-analysis. Am. J. Med. 2010;123(7):612–624. DOI: 10.1016/j.amjmed.2009.12.021.
7. Дубенко О.Е., Гаврюшин А.Ю., Зубков А.В., Екимова С.В., Ковтунов О.В. Осложнения мигрени. Мигренозный инсульт: анализ клинических случаев. Международный неврологический журнал. 2020;16(6):60–66. DOI: 10.22141/2224-0713.16.6.2020.215142.
8. Kruit M.C., van Buchem M.A., Launer L.J., Terwindt G.M., Ferrari M.D. Migraine is associated with an increased risk of deep white matter lesions, subclinical posterior circulation infarcts and brain iron accumulation: the population-based MRI camera study. Cephalalgia. 2010;30(2):129–136. DOI: 10.1111/j.1468-2982.2009.01904.x.
9. Tietjen G.E., Herial N.A., White L., Utley C., Kosmyna J.M., Khuder S.A. Migraine and biomarkers of endothelial activation in young women. Stroke. 2009;40(9):2977–2982. DOI: 10.1161/STROKEAHA.109.547901.
10. Sarchielli P., Alberti A., Coppola F., Baldi A., Gallai B., Floridi A. et al. Platelet-activating factor (PAF) in internal jugular venous blood of migraine without aura patients assessed during migraine attacks. Cephalalgia. 2004;24(8):623–630. DOI: 10.1111/j.1468-2982.2003.00717.x.
Review
For citations:
Plotnikov D.M., Alifirova V.M., Mosienko E.S. A clinical case of migrainous stroke. Bulletin of Siberian Medicine. 2023;22(2):176-181. https://doi.org/10.20538/1682-0363-2023-2-176-181
Views:
507
Email this article 